{"title":"评估减毒鼠伤寒沙门氏菌(STMΔznuABC)对犬乳腺癌相关成纤维细胞的抗癌活性。","authors":"Barbara Chirullo , Floriana Fruscione , Genny Del Zotto , Filippo Dell'Anno , Michela Tarantino , Ilaria Porcellato , Paola Petrucci , Chiara Grazia De Ciucis , Antonello Bufalari , Lisa Guardone , Katia Cappelli , Giulia Moretti , Samanta Mecocci , Eleonora Monti , Livia De Paolis , Elisabetta Razzuoli","doi":"10.1016/j.rvsc.2024.105438","DOIUrl":null,"url":null,"abstract":"<div><div>Bacteria-mediated treatments gained increasing attention as alternative therapies against tumors. An attenuated mutant strain of <em>Salmonella enterica</em> serovar Typhimurium (STMΔznuABC) has recently been considered as a potential new anti-cancer strategy. However, it is unclear whether this activity is tumor-induced or species-specific, and no data are available regarding STMΔznuABC on canine mammary tumors (CMTs). This study aimed to investigate the ability of STMΔznuABC in modulating the response of CMTs, focusing on cancer-associated fibroblasts. Four CMT cell lines (CF33, TM51, TM52 TM53) were treated with STMΔznuABC. Then, antiproliferative activity (MTT assay), bacterial invasion, and CMT cell lines gene expression analysis (RT-qPCR) of genes involved in immune response and cancer aggressiveness were evaluated. STMΔznuABC penetrated in TM51, TM52, TM53, and CF33 cell lines, causing a significant reduction of cell viability. Moreover, the expression of several genes was significantly modulated in all CMT cell lines: STMΔznuABC infection determined a significant up-regulation of <em>CXCL8</em>, <em>IL18</em>, <em>IL10</em>, <em>TLR4</em> and <em>RAD51</em>, while <em>CD14</em>, <em>IL6</em>, <em>CXCR4</em>, <em>P53</em>, <em>PTEN</em>, <em>STAT5</em>, <em>TLR5</em> and <em>TGFB1</em> were downregulated in TM53. In CF33, <em>CXCL8</em> and <em>P53</em> were upregulated, while <em>MYD88</em>, <em>MD2</em>, <em>IL18</em>, <em>TLR4,5</em>, <em>TGFB1</em> were downregulated. In TM52, <em>CXCL8</em>, <em>CD44</em> and <em>MD2</em> were upregulated and <em>PTEN</em> was downregulated, while in TM51 <em>CXCL8</em>, <em>CD44</em> and <em>ErbB2</em> were downregulated. We demonstrated the anti-proliferative and immuno-modulatory activity of STMΔznuABC in CMTs, paving the way for potential new anti-cancer treatments.</div></div>","PeriodicalId":21083,"journal":{"name":"Research in veterinary science","volume":"180 ","pages":"Article 105438"},"PeriodicalIF":2.2000,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Evaluation of attenuated Salmonella Typhimurium (STMΔznuABC) anticancer activity on canine mammary cancer-associated fibroblasts\",\"authors\":\"Barbara Chirullo , Floriana Fruscione , Genny Del Zotto , Filippo Dell'Anno , Michela Tarantino , Ilaria Porcellato , Paola Petrucci , Chiara Grazia De Ciucis , Antonello Bufalari , Lisa Guardone , Katia Cappelli , Giulia Moretti , Samanta Mecocci , Eleonora Monti , Livia De Paolis , Elisabetta Razzuoli\",\"doi\":\"10.1016/j.rvsc.2024.105438\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Bacteria-mediated treatments gained increasing attention as alternative therapies against tumors. An attenuated mutant strain of <em>Salmonella enterica</em> serovar Typhimurium (STMΔznuABC) has recently been considered as a potential new anti-cancer strategy. However, it is unclear whether this activity is tumor-induced or species-specific, and no data are available regarding STMΔznuABC on canine mammary tumors (CMTs). This study aimed to investigate the ability of STMΔznuABC in modulating the response of CMTs, focusing on cancer-associated fibroblasts. Four CMT cell lines (CF33, TM51, TM52 TM53) were treated with STMΔznuABC. Then, antiproliferative activity (MTT assay), bacterial invasion, and CMT cell lines gene expression analysis (RT-qPCR) of genes involved in immune response and cancer aggressiveness were evaluated. STMΔznuABC penetrated in TM51, TM52, TM53, and CF33 cell lines, causing a significant reduction of cell viability. Moreover, the expression of several genes was significantly modulated in all CMT cell lines: STMΔznuABC infection determined a significant up-regulation of <em>CXCL8</em>, <em>IL18</em>, <em>IL10</em>, <em>TLR4</em> and <em>RAD51</em>, while <em>CD14</em>, <em>IL6</em>, <em>CXCR4</em>, <em>P53</em>, <em>PTEN</em>, <em>STAT5</em>, <em>TLR5</em> and <em>TGFB1</em> were downregulated in TM53. In CF33, <em>CXCL8</em> and <em>P53</em> were upregulated, while <em>MYD88</em>, <em>MD2</em>, <em>IL18</em>, <em>TLR4,5</em>, <em>TGFB1</em> were downregulated. In TM52, <em>CXCL8</em>, <em>CD44</em> and <em>MD2</em> were upregulated and <em>PTEN</em> was downregulated, while in TM51 <em>CXCL8</em>, <em>CD44</em> and <em>ErbB2</em> were downregulated. We demonstrated the anti-proliferative and immuno-modulatory activity of STMΔznuABC in CMTs, paving the way for potential new anti-cancer treatments.</div></div>\",\"PeriodicalId\":21083,\"journal\":{\"name\":\"Research in veterinary science\",\"volume\":\"180 \",\"pages\":\"Article 105438\"},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2024-10-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Research in veterinary science\",\"FirstCategoryId\":\"97\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0034528824003059\",\"RegionNum\":3,\"RegionCategory\":\"农林科学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"VETERINARY SCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research in veterinary science","FirstCategoryId":"97","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0034528824003059","RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"VETERINARY SCIENCES","Score":null,"Total":0}
Evaluation of attenuated Salmonella Typhimurium (STMΔznuABC) anticancer activity on canine mammary cancer-associated fibroblasts
Bacteria-mediated treatments gained increasing attention as alternative therapies against tumors. An attenuated mutant strain of Salmonella enterica serovar Typhimurium (STMΔznuABC) has recently been considered as a potential new anti-cancer strategy. However, it is unclear whether this activity is tumor-induced or species-specific, and no data are available regarding STMΔznuABC on canine mammary tumors (CMTs). This study aimed to investigate the ability of STMΔznuABC in modulating the response of CMTs, focusing on cancer-associated fibroblasts. Four CMT cell lines (CF33, TM51, TM52 TM53) were treated with STMΔznuABC. Then, antiproliferative activity (MTT assay), bacterial invasion, and CMT cell lines gene expression analysis (RT-qPCR) of genes involved in immune response and cancer aggressiveness were evaluated. STMΔznuABC penetrated in TM51, TM52, TM53, and CF33 cell lines, causing a significant reduction of cell viability. Moreover, the expression of several genes was significantly modulated in all CMT cell lines: STMΔznuABC infection determined a significant up-regulation of CXCL8, IL18, IL10, TLR4 and RAD51, while CD14, IL6, CXCR4, P53, PTEN, STAT5, TLR5 and TGFB1 were downregulated in TM53. In CF33, CXCL8 and P53 were upregulated, while MYD88, MD2, IL18, TLR4,5, TGFB1 were downregulated. In TM52, CXCL8, CD44 and MD2 were upregulated and PTEN was downregulated, while in TM51 CXCL8, CD44 and ErbB2 were downregulated. We demonstrated the anti-proliferative and immuno-modulatory activity of STMΔznuABC in CMTs, paving the way for potential new anti-cancer treatments.
期刊介绍:
Research in Veterinary Science is an International multi-disciplinary journal publishing original articles, reviews and short communications of a high scientific and ethical standard in all aspects of veterinary and biomedical research.
The primary aim of the journal is to inform veterinary and biomedical scientists of significant advances in veterinary and related research through prompt publication and dissemination. Secondly, the journal aims to provide a general multi-disciplinary forum for discussion and debate of news and issues concerning veterinary science. Thirdly, to promote the dissemination of knowledge to a broader range of professions, globally.
High quality papers on all species of animals are considered, particularly those considered to be of high scientific importance and originality, and with interdisciplinary interest. The journal encourages papers providing results that have clear implications for understanding disease pathogenesis and for the development of control measures or treatments, as well as those dealing with a comparative biomedical approach, which represents a substantial improvement to animal and human health.
Studies without a robust scientific hypothesis or that are preliminary, or of weak originality, as well as negative results, are not appropriate for the journal. Furthermore, observational approaches, case studies or field reports lacking an advancement in general knowledge do not fall within the scope of the journal.